AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32459738 — intervention group
Group type: EXPERIMENTAL
Intervention: 13-week exercise-based intervention group (n = 33)
Number of subjects: 64
Study 36172635 — intervention group
Group type: EXPERIMENTAL
Intervention: Big bubble deep anterior lamellar keratoplasty (BB-DALK)
Number of subjects: 25
Study 36172635 — intervention group
Group type: COMPARATOR
Intervention: Manual dissection due to failed BB technique
Number of subjects: 25
Study 35776949 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 10
Study 35776949 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingerstick meter
Number of subjects: 10
Study 32756839 — intervention group
Group type: EXPERIMENTAL
Intervention: Seeding rate of 311,000 plants ha‐1
Number of subjects: 6
Study 32756839 — intervention group
Group type: EXPERIMENTAL
Intervention: Seeding rate of 360,000 plants ha‐1 (fixed population)
Number of subjects: 6
Study 32756839 — intervention group
Group type: EXPERIMENTAL
Intervention: Seeding rate of 422,000 plants ha‐1
Number of subjects: 6
Study 32756839 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision strategy of increasing 20% seed population in lower ECa zones and decreasing 20% in higher ECa zones
Number of subjects: 6
Study 35570106 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophagogastrostomy with circular stapler (CS)
Number of subjects: 76
Study 35570106 — intervention group
Group type: EXPERIMENTAL
Intervention: Double flap (DF) reconstruction
Number of subjects: 76
Study 35570106 — intervention group
Group type: COMPARATOR
Intervention: Double tract (DT) reconstruction
Number of subjects: 76
Study 32978675 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedling and 5% retinoic acid
Number of subjects: 42
Study 32978675 — intervention group
Group type: COMPARATOR
Intervention: 5% retinoic acid alone
Number of subjects: 42
Study 32150017 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session treatment group (26 patients)
Number of subjects: 53
Study 32150017 — intervention group
Group type: COMPARATOR
Intervention: Weekly management group (27 patients)
Number of subjects: 53
Study 35351871 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity counselling intervention (introductory behavioural coaching session followed by eight weekly follow-up sessions)
Number of subjects: 14
Study 35351871 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity counselling intervention
Number of subjects: 14
Study 34633323 — intervention group
Group type: EXPERIMENTAL
Intervention: VR condition
Number of subjects: 114
Study 34633323 — intervention group
Group type: COMPARATOR
Intervention: Non-VR (control) condition
Number of subjects: 114
Study 34905661 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency rTMS (3 Hz)
Number of subjects: 45
Study 34905661 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency rTMS (1 Hz)
Number of subjects: 45
Study 34905661 — intervention group
Group type: COMPARATOR
Intervention: SHAM stimulation
Number of subjects: 45
Study 33971485 — intervention group
Group type: EXPERIMENTAL
Intervention: Mind-body activity program
Number of subjects: 13
Study 33971485 — intervention group
Group type: EXPERIMENTAL
Intervention: ActiGraph wear reminders
Number of subjects: 13
Study 35685611 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 77
Study 35685611 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 77
Study 35685611 — intervention group
Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia (TIVA) with propofol and remifentanil
Number of subjects: 77
Study 34343108 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1000–2000 mg daily for 3 months)
Number of subjects: 65
Study 34343108 — intervention group
Group type: COMPARATOR
Intervention: Insulin (non-MET group)
Number of subjects: 65
Study 33433509 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% curcumin mouthwash
Number of subjects: 74
Study 33433509 — intervention group
Group type: COMPARATOR
Intervention: 0.15% benzydamine mouthwash
Number of subjects: 74
Study 35917806 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin 40 IU
Number of subjects: 42
Study 35917806 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 42
Study 33298193 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Counselling for Adolescents (IPC-A)
Number of subjects: 60
Study 33298193 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 60
Study 35816836 — intervention group
Group type: EXPERIMENTAL
Intervention: Household food insecurity (FI)
Number of subjects: 534
Study 35816836 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline BMI
Number of subjects: 534
Study 35816836 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary quality (measured by USDA Healthy Eating Index)
Number of subjects: 534
Study 33957531 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial Displacement Calcaneal Osteotomy (MDCO)
Number of subjects: 42
Study 33957531 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral Column Lengthening (LCL)
Number of subjects: 42
Study 35620325 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet (MedDiet)
Number of subjects: 44
Study 35620325 — intervention group
Group type: COMPARATOR
Intervention: Healthy Eating Guidelines (HEG)
Number of subjects: 44
Study 34861827 — intervention group
Group type: EXPERIMENTAL
Intervention: CRAFT delivered through individual sessions
Number of subjects: 11
Study 34861827 — intervention group
Group type: EXPERIMENTAL
Intervention: CRAFT delivered through group sessions
Number of subjects: 11
Study 34861827 — intervention group
Group type: EXPERIMENTAL
Intervention: CRAFT written material as a supplement
Number of subjects: 11
Study 34487222 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie-restricted ketogenic diet and intermittent fasting (KD-IF)
Number of subjects: 50
Study 34487222 — intervention group
Group type: COMPARATOR
Intervention: Standard diet (SD)
Number of subjects: 50
Study 34487222 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glucose
Number of subjects: 50
Study 33831623 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol
Number of subjects: 57
Study 33831623 — intervention group
Group type: COMPARATOR
Intervention: Control (no inhaled salbutamol)
Number of subjects: 57
Study 33739358 — intervention group
Group type: EXPERIMENTAL
Intervention: Sending 21 email messages to family pediatricians
Number of subjects: 141
Study 34975166 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (BUP)
Number of subjects: 40
Study 34975166 — intervention group
Group type: EXPERIMENTAL
Intervention: Butorphanol (BUT)
Number of subjects: 40
Study 34975166 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 40
Study 33824226 — intervention group
Group type: EXPERIMENTAL
Intervention: Choir intervention (2-hr ensemble singing + 1-hr home vocal training weekly)
Number of subjects: 0
Study 33824226 — intervention group
Group type: EXPERIMENTAL
Intervention: Choir intervention
Number of subjects: 0
Study 33824226 — intervention group
Group type: COMPARATOR
Intervention: Control group (listened to a 3-hr playlist weekly, attended concerts, and socialized online)
Number of subjects: 0
Study 35275776 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated cycloplegic refraction using Retinomax K‐plus 5
Number of subjects: 213
Study 35275776 — intervention group
Group type: COMPARATOR
Intervention: Manual cycloplegic refraction using retinoscopy
Number of subjects: 213
Study 32302064 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium glucoheptonate (250 mg/10 mL, two oral ampoules)
Number of subjects: 24
Study 32302064 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate (500 mg elemental calcium, one effervescent tablet)
Number of subjects: 24
Study 32302064 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium glucoheptonate and Calcium carbonate
Number of subjects: 24
Study 35984522 — intervention group
Group type: EXPERIMENTAL
Intervention: Low‐cost simulated pelvic model for kinesthetic learning during the video module
Number of subjects: 40
Study 35984522 — intervention group
Group type: COMPARATOR
Intervention: Interactive video module alone
Number of subjects: 40
Study 34326053 — intervention group
Group type: EXPERIMENTAL
Intervention: Identification of open bile ducts with administration of 20-40 mL SMOFlipid5% in the bile tract
Number of subjects: 210
Study 34326053 — intervention group
Group type: COMPARATOR
Intervention: Identification with a white gauze on the liver resection surface
Number of subjects: 210
Study 33213722 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 2365
Study 33213722 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 2365
Study 35348447 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model for overall survival (OS)
Number of subjects: 3061
Study 35348447 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model for cancer-specific survival (CSS)
Number of subjects: 3061
Study 35348447 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model
Number of subjects: 3061
Study 32852889 — intervention group
Group type: EXPERIMENTAL
Intervention: Manuka honey irrigation
Number of subjects: 13
Study 35190884 — intervention group
Group type: EXPERIMENTAL
Intervention: Cention N®
Number of subjects: 66
Study 35190884 — intervention group
Group type: EXPERIMENTAL
Intervention: EQUIA Forte®
Number of subjects: 66
Study 35190884 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtek™ Z350
Number of subjects: 66
Study 34518246 — intervention group
Group type: EXPERIMENTAL
Intervention: Friendship Bench (FB) intervention, details on dosage and duration not specified.
Number of subjects: 0
Study 34518246 — intervention group
Group type: COMPARATOR
Intervention: Cluster randomised controlled trial of the optimised Friendship Bench intervention, details on dosage and duration not specified.
Number of subjects: 0
Study 35062944 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive pursed lip breathing ventilation (PLBV) during the second night of the study
Number of subjects: 31
Study 35062944 — intervention group
Group type: COMPARATOR
Intervention: Established non-invasive ventilation (NIV) treatment
Number of subjects: 31
Study 34078374 — intervention group
Group type: EXPERIMENTAL
Intervention: STAR (Sepsis Transition and Recovery program)
Number of subjects: 4032
Study 34078374 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 4032
Study 32502072 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal Grill Illusion (TGI) with neutral, positive (placebo), and negative (nocebo) instructions
Number of subjects: 64
Study 32502072 — intervention group
Group type: COMPARATOR
Intervention: Single-temperature stimulation
Number of subjects: 64
Study 34570177 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam, 125 mg, twice daily for 4 weeks
Number of subjects: 34
Study 34570177 — intervention group
Group type: COMPARATOR
Intervention: Placebo, twice daily for 4 weeks
Number of subjects: 34
Study 32205751 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal injection of botulinum toxin (8U)
Number of subjects: 29
Study 32205751 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular injection of botulinum toxin
Number of subjects: 29
Study 32205751 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 29
Study 36224574 — intervention group
Group type: EXPERIMENTAL
Intervention: Online technology (OLT)
Number of subjects: 40
Study 36224574 — intervention group
Group type: COMPARATOR
Intervention: Paper format (PF)
Number of subjects: 40
Study 36224574 — intervention group
Group type: EXPERIMENTAL
Intervention: Both OLT and PF
Number of subjects: 40
Study 33323473 — intervention group
Group type: EXPERIMENTAL
Intervention: Steering immunosuppressive therapy by levels of virus-specific T cells
Number of subjects: 64
Study 33323473 — intervention group
Group type: COMPARATOR
Intervention: Control group with trough-level monitoring of immunosuppressants
Number of subjects: 64
Study 33177722 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum rehabilitation nursing (n=50)
Number of subjects: 100
Study 33177722 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=50)
Number of subjects: 100
Study 33955170 — intervention group
Group type: EXPERIMENTAL
Intervention: HIVRR + MF intervention
Number of subjects: 354
Study 33955170 — intervention group
Group type: COMPARATOR
Intervention: HIVRR intervention
Number of subjects: 354
Study 32202350 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicinal plant mix (wormwood, chamomile, fumitory, and mallow) with meadow hay:barley grain (MH:B) in a ratio of 100/600/300 w/w/w
Number of subjects: 0
Study 32202350 — intervention group
Group type: EXPERIMENTAL
Intervention: Single plant substrates (wormwood, chamomile, fumitory, and mallow)
Number of subjects: 0
Study 32202350 — intervention group
Group type: COMPARATOR
Intervention: Control group (MH:B)
Number of subjects: 0
Study 32202350 — intervention group
Group type: EXPERIMENTAL
Intervention: Total polyphenols content in plant extracts
Number of subjects: 0
Study 32202350 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciliate protozoan population in rumen fluid after 24 hr of fermentation
Number of subjects: 0
Study 35102098 — intervention group
Group type: EXPERIMENTAL
Intervention: FSFI‐19 <21
Number of subjects: 998
Study 34515737 — intervention group
Group type: EXPERIMENTAL
Intervention: CONNECT intervention (3 monthly visits with trained oncology nurses)
Number of subjects: 672
Study 33393675 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically proxied inhibition of IL‐6 signalling
Number of subjects: 0
Study 32192407 — intervention group
Group type: EXPERIMENTAL
Intervention: F-care
Number of subjects: 114
Study 32192407 — intervention group
Group type: COMPARATOR
Intervention: Closurefast
Number of subjects: 114
Study 32633650 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing nature photos
Number of subjects: 757
Study 32633650 — intervention group
Group type: COMPARATOR
Intervention: Viewing urban scenes or neutral objects (control conditions)
Number of subjects: 757
Study 32854734 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital parental materials (online animated films and a parent-teen homework exercise)
Number of subjects: 8000
Study 33725166 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical debridement (NST)
Number of subjects: 45
Study 33725166 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical debridement (ST)
Number of subjects: 45
Study 33725166 — intervention group
Group type: COMPARATOR
Intervention: Comparison between NST and ST
Number of subjects: 45
Study 33143674 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin users
Number of subjects: 86188
Study 33143674 — intervention group
Group type: COMPARATOR
Intervention: Statin non-users
Number of subjects: 86188
Study 36122756 — intervention group
Group type: EXPERIMENTAL
Intervention: Nanocurcumin
Number of subjects: 60
Study 36122756 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33430913 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemipelvis restricted group
Number of subjects: 14
Study 33430913 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemipelvis unrestricted group
Number of subjects: 14
Study 33430913 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups when ASL, SBL, and SPL failed
Number of subjects: 14
Study 33469657 — intervention group
Group type: EXPERIMENTAL
Intervention: Encephaloduroarteriosynangiosis (EDAS)
Number of subjects: 52
Study 33469657 — intervention group
Group type: COMPARATOR
Intervention: Intensive medical management (IMM)
Number of subjects: 52
Study 32994236 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive bandage for 3 days
Number of subjects: 180
Study 32994236 — intervention group
Group type: COMPARATOR
Intervention: Below-elbow cast for 2 weeks
Number of subjects: 180
Study 32029039 — intervention group
Group type: EXPERIMENTAL
Intervention: REE group (n = 29)
Number of subjects: 58
Study 32029039 — intervention group
Group type: COMPARATOR
Intervention: HBREE group (n = 29)
Number of subjects: 58
Study 32029039 — intervention group
Group type: EXPERIMENTAL
Intervention: REE group
Number of subjects: 58
Study 32029039 — intervention group
Group type: COMPARATOR
Intervention: HBREE group
Number of subjects: 58
Study 32090720 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Training (CT) exercises over 15 weeks
Number of subjects: 93
Study 32090720 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 93
Study 32090720 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Training (CT)
Number of subjects: 93
Study 33218561 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% intensity PNF stretching (P40)
Number of subjects: 64
Study 33218561 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% intensity PNF stretching (P10)
Number of subjects: 64
Study 33218561 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% intensity PNF stretching with toe touch (P40 with TT)
Number of subjects: 64
Study 33218561 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% intensity PNF stretching with toe touch (P10 with TT)
Number of subjects: 64
Study 34111771 — intervention group
Group type: EXPERIMENTAL
Intervention: PNC-txt (peer network counseling text)
Number of subjects: 101
Study 34326209 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotinamide mononucleotide (NMN) therapy
Number of subjects: 2
Study 34326209 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 2
Study 32289854 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic procedures (clipping and coagulation of visible vessels)
Number of subjects: 110
Study 36050353 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom standing desk intervention for 16 weeks
Number of subjects: 49
Study 36050353 — intervention group
Group type: COMPARATOR
Intervention: Traditional sitting classes (control)
Number of subjects: 49
Study 33481866 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg
Number of subjects: 250
Study 33481866 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 10 mg
Number of subjects: 250
Study 32072749 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week lifestyle intervention including nutrition education (1 h/wk) and moderate-to-vigorous physical activity (3 h/wk)
Number of subjects: 136
Study 32072749 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 136
Study 35359480 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch (HES) 130/0.4
Number of subjects: 126
Study 35359480 — intervention group
Group type: COMPARATOR
Intervention: 0.9% normal saline (NS)
Number of subjects: 126
Study 35359480 — intervention group
Group type: COMPARATOR
Intervention: 6% hydroxyethyl starch (HES) 130/0.4 vs 0.9% normal saline (NS)
Number of subjects: 126
Study 34774745 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon pump (IABP)
Number of subjects: 0
Study 34774745 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 32056358 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 48
Study 32056358 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 48
Study 33331805 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 1: 10 min of aerobic exercise after five cycles of one minute of static stretching
Number of subjects: 15
Study 33331805 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 2: 10 min of aerobic exercise before static stretching
Number of subjects: 15
Study 33331805 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention 3: 5 min of aerobic exercise both before and after static stretching
Number of subjects: 15
Study 34098955 — intervention group
Group type: EXPERIMENTAL
Intervention: mepolizumab 750, 250, or 75 mg intravenously
Number of subjects: 1878
Study 34098955 — intervention group
Group type: EXPERIMENTAL
Intervention: mepolizumab 75 mg intravenously or 100 mg subcutaneously
Number of subjects: 1878
Study 34098955 — intervention group
Group type: EXPERIMENTAL
Intervention: mepolizumab 100 mg subcutaneously
Number of subjects: 1878
Study 34098955 — intervention group
Group type: EXPERIMENTAL
Intervention: mepolizumab
Number of subjects: 1878
Study 34098955 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1878
Study 36001254 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer support and mobile application-based walking programme
Number of subjects: 72
Study 36001254 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study 34614511 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg)
Number of subjects: 0
Study 34614511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33054367 — intervention group
Group type: EXPERIMENTAL
Intervention: ACURATE neo
Number of subjects: 796
Study 33054367 — intervention group
Group type: COMPARATOR
Intervention: CoreValve Evolut
Number of subjects: 796
Study 35190385 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg/day
Number of subjects: 15
Study 34342153 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic model of the nomogram in the development group
Number of subjects: 3820
Study 34342153 — intervention group
Group type: EXPERIMENTAL
Intervention: Prognostic model of the nomogram in the validation group
Number of subjects: 3820
Study 34342153 — intervention group
Group type: EXPERIMENTAL
Intervention: High risk prognosis index
Number of subjects: 3820
Study 32602376 — intervention group
Group type: COMPARATOR
Intervention: No sleep problems
Number of subjects: 408
Study 32602376 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep problems with no-to-minimal-impact
Number of subjects: 408
Study 32602376 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep problems with moderate-to-quite-a-bit of impact
Number of subjects: 408
Study 35197469 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 11500000
Study 35197469 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adults and individuals with comorbidities
Number of subjects: 11500000
Study 35197469 — intervention group
Group type: EXPERIMENTAL
Intervention: Pragmatic RCT using non-specific endpoints
Number of subjects: 11500000
Study 33314364 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate multilevel (MM) models
Number of subjects: 0